T. Rowe Price Global Value Eq C Acc
GlobalPricing frequency
Daily
Dealing cut off time
10:45
Type
OEIC
Yield
0.72%
NAV
£18.7221
Income frequency
Annually
Ongoing charge
0.76%
Latest actual NAV date
16-11-2026
ISIN
GB00BLFG9N53
UCITS
Yes
Growth of 10k
Asset allocation
Top 10 holdings
| Holdings 30/09/2026 | % of assets |
|---|---|
| Microsoft Corp | 6.80 |
| Meta Platforms Inc Class A | 3.20 |
| Alphabet Inc Class C | 3.06 |
| ExxonMobil Holdings Corp | 2.12 |
| AstraZeneca PLC | 1.99 |
| JPMorgan Chase & Co | 1.99 |
| Micron Technology Inc | 1.79 |
| Gilead Sciences Inc | 1.74 |
| AbbVie Inc | 1.51 |
| Cencora Inc | 1.51 |
Investment objective
To increase the value of its shares, through growth in the value of its investments over the long term (a minimum of 5 years). The fund is actively managed and invests at least 80% of total assets in a diversified portfolio of undervalued shares and related securities issued by companies anywhere in the world, including emerging markets (up to 10% of the total assets of the fund). Value is assessed by looking at indicators such as cash flows, dividends and earnings to identify securities which the investment manager believes have been undervalued by the market.